Four Partners Recognized as “Top 250 Women in Litigation” by Benchmark Litigation

Benchmark Litigation named Kirkland partners Devora Allon, Alli Brown, Dale Cendali and Sandra Goldstein to its 2026 list of the “Top 250 Women in Litigation.” The honorees participated in some of the most impactful recent litigation matters and were chosen through several phases of research, including review of their recent case work, peer review and client feedback.

Alli was also named one of the “Top 10 Women Litigators in the U.S.”

Renowned for our experience in complex litigation and arbitration, Kirkland’s litigation team anticipates clients’ needs and outperforms their expectations. We believe that the best litigation results — whether achieved in court or across the bargaining table — occur when the lawyers are fully prepared to try the case through verdict. Our focus on trial-readiness drives successful and more cost-efficient results for clients, as critical issues are identified early and then used to maximum advantage in the litigation and negotiation processes.

Alli is a nationally recognized trial lawyer who represents clients in high-stakes jury trials and has a proven track record of success in some of the most challenging jurisdictions around the country. She has successfully represented top multinational corporations across the pharmaceutical, life sciences and consumer goods industries in their most high-profile jury trials.

Dale is a nationally recognized leader in the field of intellectual property litigation, having successfully litigated and tried numerous high-profile cases and argued before the U.S. Supreme Court. Her practice encompasses copyright, trademark, false advertising, patent, internet and trade secrets law, as well as defamation, the right of publicity, privacy, complex contract disputes and similar areas like electronic discovery.

Devora is a leading litigator and trial lawyer whose broad practice focuses on antitrust, product liability and other commercial disputes. She has significant trial experience, securing seven trial wins since 2015. Her clients have included Apple, GlaxoSmithKline, Starwood Capital Group, Sun Pharma, Teva, Torrent Pharmaceuticals and Upsher-Smith Laboratories.

Sandra has a broad litigation practice, with a particular focus on securities, M&A and commercial disputes. She represents clients, including corporations and their boards, in all manner of securities litigation — stock drop class actions, shareholder derivative suits, litigation demands — often securing pretrial wins, including a major summary judgment victory in a multibillion-dollar securities fraud class action lawsuit.